An interventional study of Surgicel in Non-variceal Upper Gastrointestinal Bleeding, sponsored by Soonchunhyang University Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 20 Years to 75 Years. Per ClinicalTrials.gov, last updated 2014-11-19.
Sponsored by Soonchunhyang University Hospital · Not applicable and Interventional
The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding
339 studies on the registry are indexed under Gastrointestinal Hemorrhage; 79 are open to participants now.
Browse Gastrointestinal Hemorrhage studies →Soonchunhyang University Hospital is the lead sponsor of 61 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Surgicel
Rebleeding rate at the second look endoscopy
Time frame: 2 year
This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Soonchunhyang University Hospital